STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #91 by analyst upside · 2026-06-27
LGVN
Longeveron Inc.
Healthcare · Market Cap $23M · P/E 0x
ANALYST PRICE TARGET
+899.3%
implied upside to consensus target
Current Price $0.72
Consensus Target $7.15
Bull Target $10.45
Bear Target $3.0
Analysts Covering 3
ANALYST CONSENSUS - STRONG BUY
Strong Buy
2
Buy
2
Hold
0
Sell
0
52-Week Low $0.47
52-Week High $1.8
YTD Return +20.7%
FUNDAMENTALS
Market Cap $23M
P/E Ratio (TTM) N/A
Forward P/E -0.5x
EPS (TTM) $-1.14
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.47
52-Week High $1.8
Current Price $0.72
Bear Target $3.0
Bull Target $10.45
● Now $0.72 ● Target $7.15
TRADING DATA
Avg Volume 495K
YTD Return +20.7%
Analyst Count 3
Consensus Strong Buy
Upside to Target +899.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Longeveron Inc. (LGVN) is currently trading at $0.72 with a Wall Street consensus price target of $7.15, implying potential upside of 899.3% over the next 12 months. 3 analysts currently cover LGVN, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.45, while the most cautious has a target of $3.0.

LGVN operates in the Healthcare sector with a market capitalisation of $23M. The stock is up 20.7% year-to-date and is currently trading near the lower end of its 52-week range of $0.47 – $1.8.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for LGVN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Maxim Group ↓ Downgrade
Buy → Hold 2026-05-11 28% win rate (40 calls)
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-05-04 31% win rate (48 calls)
Roth Capital — Reiterated
Buy → Buy 2025-08-15 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-03-21 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-03 31% win rate (48 calls)
Roth MKM ● Initiated
Buy 2024-12-05 25% win rate (12 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-11-25 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-11-04 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
38
out of 100
Coverage depth
11/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →